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Drug Matrix cell A4: Interventions; Psychosocial therapies
S  Seminal  studies  K  Key studies  R  Reviews  G  Guidance  MORE  Search for more studies
K  Match counsel l ing style to the cl ient (2003). US tria l  shows that structure and directiveness  are key dimensions  on which therapies  can be matched to cl ient
characteristics .
K  Visual  a ids  enhance counsel l ing (2009). Node-l ink maps are flow charts  of a  patient’s  a ims and plans  which faci l i tate patient-counsel lor communication; in
this  study they helped methadone patients  reduce i l legal  opiate use and probably a lso cocaine use.
K  Couples  therapy improves  the l ives  of both partners  (2003). Proven most fi rmly for a lcohol ics , this  study showed that the benefi ts  of systematical ly involving a
patient’s  wife/partner in their treatment extends to the use of an opiate-blocking medication to sustain abstinence from heroin and al l ied drugs; relative to non-
fami ly a l ternative therapies , there were also improvements  in fami ly functioning and other socia l  and legal  domains. Simi lar story for methadone patients  (2001).
R  Common relationship factors  (American Psychological  Association, 2011). Introduces  reviews based on the understanding that treatment methods are not
s imply technical  interventions, but ways  cl ient and therapist relate, so cannot be divorced from the relationship between cl ient and therapist. From here you can
find the component reviews and the overal l  conclus ions  (2011) reached by the association’s  task force.
R  Directiveness  is  a  key di fference between therapies  (2006). The interpersonal  style (eg, directive v. patient-led) associated with di fferent therapies  is  why some
work better with some cl ients  than others .
R  Reviews of tria ls  of motivational  interviewing (Cochrane review, 2011) and cognitive-behavioural  therapy (2009) suggest any structured approach grounded in
an coherent theory is  as  good as  any other. We have, i t was  argued, been looking in the wrong direction for therapy’s  active ingredients .
R  Motivational  starts  to treatment (2005). Findings  review discovers  that manual ised motivational  interviewing is  not a lways  better than more directive
approaches  as  a  way of engaging cl ients  with treatment.
R  Mindfulness  meditation takes  i ts  place among addiction therapies  (2009). Increas ingly popular, variants  of mindfulness  meditation are among the ‘third wave’
of behavioural  therapies  a l lying Western and Eastern traditions. This  fi rst review of their appl ication to addiction finds  them equivalent to other structured
therapies , but an important later study (2014) suggests  otherwise. See also this  more recent review (2014).
R  Peer-based addiction recovery (2009). Includes  a  chapter on the evidence for NA, AA and al l ied mutual  support networks  and treatments  based on the same
principles  and networks. See also this  review (2004) of how treatment services  can promote mutual  a id and this  synthes is  of studies  (1999) of approaches  based
on AA/NA’s  12-steps  versus  a l ternative treatments .
R  Therapeutic communities  certainly work whi le res idents  stay (2012). Shortcomings  in the original  s tudies  prevented a fi rm conclus ion on the lasting benefi ts  of
res identia l  communities  of patients  exerting mutual ly therapeutic influences, but i t was  clear that whi le res idents  stayed, substance use was s igni ficantly reduced.
R  Reserve therapeutic communities  for most vulnerable patients  (2013). Review speci fic to users  of i l legal  drugs  argues  therapeutic communities  should be
reserved for drug addicts  with multiple and severe problems who do not do wel l  in outpatient treatment due to the lack of structure and supports , or the fact that
they l ive in high drug use areas.
R  Some patients  get worse (2005). Reminder that after psychosocial  therapy up to 15% of cl ients  end up worse than before; some of the reasons  are to do with poor
therapy including a  weak relationship, fa i l ing to assess  how cl ients  are doing, being confrontational  or cri tical , low or inappropriate expectations, and lack of
chal lenge.
R  Rewards  and sanctions  for not us ing drugs  (2013). Findings  hot topic asks  whether we can dispense with counsel l ing and therapy and just punish people or
deprive them of rewards  when they use substances  in ways  they and/or we would rather they didn’t, and reward them when they behave as  we and/or they would
wish? Formal ised in to set schedules , these approaches  are known as  ‘contingency management’.
G  NICE-recommended psychosocial  interventions  ([UK] National  Insti tute for Health and Cl inical  Excel lence [NICE], 2007). UK’s  officia l  health advisory body
recommends contingency management and behavioural  couples  therapy.
G  Implementing NICE-recommended psychosocial  interventions  ([Engl ish] National  Treatment Agency for Substance Misuse, 2010). Report commiss ioned by
England’s  national  addiction treatment agency from the Bri tish Psychological  Society; includes  protocols  for conducting the main psychosocial  therapies .
G  Expert US consensus  on group therapy ([US] Substance Abuse and Mental  Health Services  Administration, 2005). Consensus  guidance on the di fferent types  of
groups, how to organise and lead them, des irable staff attributes , and staff tra ining and supervis ion.
G  No magic bul let, but treatment based on sound principles  (2006). Based on reviews commiss ioned by the American Psychological  Association; reviews evidence
and offers  in-principle guidance on how to relate to cl ients  and the content of sess ions. Argues  that these principles  “provide a more research-informed and
potentia l ly effective approach to treatment than either the appl ication of a  one-s ize-fi ts -a l l  s tandard treatment protocol  or the use of idiosyncratical ly selected
interventions”.
MORE  This  search retrieves  a l l  relevant analyses .
For subtopics  go to the subject search page or hot topics  on contingency management, res identia l  rehabi l i tation, motivational  interviewing, 12-step mutual  a id
and counsel l ing in methadone treatment.
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What is this cell about? Every treatment involves direct or indirect human interaction, but this cell is about therapies in which interaction
is intended to be the main active ingredient. Colloquially referred to as ‘talking therapies’, these are more formally categorised as
‘psychosocial’. They attempt to change how the patient reacts either directly, or via their beliefs and attitudes, how they relate to others,
and how others relate to them, in respect of which the biggest change may be the experience of being related to in a caring context
centred on your aspirations, needs and welfare. Interventions range from brief advice and counselling to extended therapies based on
psychological theories and all-embracing residential communities where clients stay for several months. Elements could include rewards
and punishments contingent on client behaviour (contingency management), leading the client to see their substance use as contrary to
desired self-images or objectives (as in motivational interviewing), harnessing social influences (as in group and family therapies and
community living arrangements), teaching the client what triggers their undesired substance use and how to manage or avoid those
triggers (as in cognitive-behavioural therapies), ways to manage thoughts and moods which otherwise might precipitate relapse (as in
mindfulness approaches), and more practical elements such as vocational rehabilitation. Whether based on research and theory, religion,
morals or experience, belief systems underlie these approaches. Most prominent in the research are the 12 steps of Alcoholics
Anonymous and allied fellowships, and the understanding that addiction can be learnt and unlearnt, which underpins major psychological
therapies, including those recommended by the UK’s official health advisory body, the National Institute for Health and Clinical
Excellence (NICE).
Where should I start? This cell is partly about the relative merits of different therapies, but also about the therapeutic properties they
share and how such ‘common factors’ can be made yet more potent. Since these factors have become seen as the major influences, let’s
start there, and in particular with the shift to focus on them made by the American Psychological Association (APA). Updating work from
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1999, in 2011 their task force analysed the literature to identify what constitutes an effective relationship between therapist and patient.
Take a look at the introductory article which lists the component reviews. From there you can access whichever of these reviews most
interests you, and the task force’s overall conclusions. Then go back a few years to the guidance offered by another APA task force which
integrated these relationship issues with the content of therapy. In both note the stress on collaborative working, and warnings against
being confrontational, hostile, pejorative, critical, rejecting, or blaming. Note too that they also cautioned that on issues like this, there
are no universal rules; unlike public health approaches, treatment is essentially the treatment of an individual.
Highlighted study One of the most consistent findings on matching therapists with clients is that directive therapists risk a backlash
from clients with a short fuse or who resist other people’s attempts to lead the interaction. Conversely, calmer patients or those who
welcome direction thrive when given more of a lead. That we found in one of our reviews applies also to substance use clients. Those
finding were about the characteristics of therapists, but therapies too differ in the directiveness they require or encourage. What if the
same therapists implement these different approaches. Would the same matching finding emerge?
That was answered in the affirmative by the results of a US study at a clinic where cocaine was the dominant drug problem. Read our
account and you will see that patients were randomly allocated to therapies designed in some ways to be at opposite poles: one highly
structured and directive; the other, less structured and non-directive, the counsellor acting primarily as a sounding board for the patient.
How far patients welcomed direction was not directly assessed, but a similar variable was – ‘learned helplessness’. Patients high on this
dimension are likely to feel the need to be given direction, while those at the opposite pole are confident in their abilities to do the
directing themselves.
Neither approach was preferable overall, but this masked different impacts on different types of clients. As expected, those characterised
by learned helplessness did better when the therapy required the counsellor to take the lead, while clients who felt more in control of
their lives did better when the less structured therapy allowed them to set the agenda. Depressed clients also did best in the structured
therapy and worst when required to take the initiative, again, potentially related to their tolerance for and need for direction.
Apart from the specific findings, the study is a reminder that it would be a mistake to take an ‘It doesn’t matter what you do’ message
from reviews and studies which average outcomes across all patients; though it might be true on average, it is not necessarily true for
each individual or for different types of patients; treatment is, as we have said, essentially the treatment of an individual.
Issues to think about
 Research may have to package; therapy does not. That last comment above brings us to an important point about the nature of
research and its links to practice. Researchers often feel they have to tightly control what is being delivered in order to know what caused
any improvements, so they manualise interventions and train and supervise therapists to make sure they follow the manual. Our review
of motivational interviewing shows this is not necessarily the best way to do therapy, which has to sensitively adapt to where the patient
is at in their journey to a commitment to tackle their substance use problems (for more see cell C4).
Similarly, researchers may prefer to deliver interventions according to a set schedule and time period to standardise them, limit costs,
equalise time spent with therapists in a comparison therapy, and have a set end date from which the follow-up period can begin. Twelve
weeks is the commonest compromise between a manageable research intervention and one which lasts long enough to possibly have the
desired impacts. As a result, 12-week treatments have collected an evidence base around them. Yet there is no reason to believe that
because 12 weeks is convenient for researchers, it is also how patients should be treated. Some manage well with much less, others will
benefit more from longer term care.
Research takes its ideas from practice, standardises and packages that practice, and then tests it. Via recommendations from authorities
reliant mainly on research findings, practitioners may then be persuaded that the researchers’ packages – now ‘evidence-based’ – are
how they too should do therapy.
Instead, treat research as an aid to developing and reflecting on practice, not a blueprint. This was the approach taken by authorities
from the British Psychological Society when they developed their guidance on implementing the main psychosocial therapies
recommended by the UK’s official health advisory body, the National Institute for Health and Clinical Excellence (NICE). The authors
insisted that though their framework “draws heavily upon treatment manuals, it enables a more comprehensive approach to
implementation than a manual alone can provide ... It allows a degree of flexibility and adaptation at the level of the individual service
user. Such flexibility may not be present in a particular manual, the development of which may instead be rooted in a specific service in a
particular health care setting.”
 Are these always the important things to do? Retrieve this guidance from an American Psychological Association task force. Skip to
the heading “Treatment factors” on page three of the PDF file. There you will read that research “suggests that a number of specific
therapeutic elements are characteristic of effective treatments”. Take a critical look at these suggestions. They include “explicitly
helping the client restructure his or her social environment in ways that support change” – or more specifically, abstinence. How feasible
is that for the clients you know of? Do they have the resources – psychological, social and material – to replace environments,
friendships, even families and intimate partners, conducive to substance use with those conducive to the opposite? Unless they can at
least go some way towards this transformation, gains from the radical social re-engineering possible in a contained environment like a
residential community remain vulnerable on discharge back to the home environment.
Next up is a “focus on client motivation for change”, possibly through exercises that get the patient to weigh up the pros and cons of
changing their substance use. But if (as many will be) patients are already committed to change, maybe it is not such a good idea to
encourage them to rehearse the good things about their substance use? On this issue see study 19 in this Findings review. Next is the
territory made its own by cognitive-behavioural therapies: “helping the client to develop awareness of repetitive patterns of thinking and
behavior that perpetuate substance use ... accompanied by a focus on helping the client learn alternative coping skills.” If this is key, why
on average do cognitive-behavioural therapies do no better than other approaches?
Then we learn that “Effective therapies attend to the affective [emotional/mood] experiences of the client, particularly in relation to their
substance use.” Yet we know too that a focus on emotions can for some patients be counterproductive. Finally, the task force identified
“strong evidence for the role of conditioning in the development and maintenance of substance use disorders,” and argued that
“repeated exposure to alcohol- or drug-related situations without using” can weaken these conditioned reactions and bolster the
patient’s confidence that they can handle such situations without using drugs. Yet for this so-called ‘cue exposure’ therapy, the UK’s
official health advisory body was unable to find a single study which met its quality criteria, leaving it, as far as NICE was concerned,
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without a research leg to stand on.
These points are made not to criticise the in general very sensible suggestions made by the task force, but to reinforce a point already
made; that generalisations are bound sometimes to be misleading in what is essentially an individualised response to an individual set of
circumstances never before encountered in precisely the same configuration.
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